½Ã°£ |
ÄÁº¥¼ÇȦ |
´ëȸÀÇ½Ç |
±³À°Àå |
8:10~9:10 Morning-S |
Case discussion - I (ÁÂÀå : ¿°È£±â) |
Case discussion - II (ÁÂÀå : ¾ç±¤ÀÍ) |
¡¡ |
CPAP case
(±è¼¼Áß, ÇÑÀüº´¿ø È£Èí±â³»°ú) |
Night owl mimicking narcolepsy
(±è±¤±â, µ¿±¹ÀÇ´ë ½Å°æ°ú) |
¡¡ |
Upper airway surgery
(±èÈ¿¿, ¼º±Õ°üÀÇ´ë À̺ñÀÎÈÄ°ú) |
RBD needing more than clonazepam
(ÀÌÁ¤¼®, ºÐ´ç¼¿ï´ëº´¿ø Á¤½Å°ú) |
¡¡ |
9:20~9:30 |
Opening / ÄÁº¥¼ÇȦ |
9:30~10:30
Plenary-S |
Plenary session (ÁÂÀå : ÃÖ¼öÀü)¡¡
¡¡
Sleep and clinical medicine - from epidemiology to clinical implications (Wing YK)
(Wing YK , Department of Psychiatry, Chinese University of Hong Kong)
|
10:30~10:50 |
Coffee Break |
10:50~12:00 Sym-¥° |
Evaluation of OSA (ÁÂÀå : ±¸¼ö±Ç) |
Sleep disorders with REM sleep abnormalities
(ÁÂÀå : È«½ÂºÀ) |
Clinical chronobiology
(ÁÂÀå : ÀÌ»ó¾Ï) |
Lab-based vs home-based PSG
(Á¶Àç¿í, ºÎ»êÀÇ´ë ½Å°æ°ú) |
Nightmare - Wing YK |
Gender difference in morningnesseveningness
(ÀÌÁ¤Èñ, °¿ø´ë Á¤½Å°ú) |
AHI vs other parameters
(ÃÖ¼öÀü, ÀÎÁ¦´ëÇб³ »ó°è¹éº´¿ø È£Èí±â³»°ú) |
Dream enacting behaviors in RBD and healthy controls
(³ë¿µÁÖ, ¿ï»êÀÇ´ë ½Å°æ°ú) |
Light therapy and its application to circadian rhythm sleep disorder
(ÀÌÁöÇö, ¼¿ï¼ö¸éŬ¸®´Ð) |
Obstructive site evaluation
(¿øźó, ¼¿ïÀÇ´ë À̺ñÀÎÈÄ°ú) |
Narcolepsy as a REM sleep abnormality
(È«½Âö, °¡Å縯´ë Á¤½Å°ú) |
How to combat jet lag
(½Å¿øö, °æÈñÀÇ´ë ½Å°æ°ú) |
12:00~13:00 |
Lunch |
13:00~14:10 Sym-¥± |
Recent advances in treatment of OSA -I
(ÁÂÀå : ÀÌÀç¼) |
Prevalence and risk factors of Insomnia across life cycle
(ÁÂÀå : À±Áø»ó) |
Comorbidities and sequale of RLS and PLMS
(ÁÂÀå : Çã°æ) |
PAP therapy
(Áö±âȯ, ÀÎÁ¦ÀÇ´ë ½Å°æ°ú) |
Adults
(Á¤±ÔÀÎ, °¡Å縯´ë Á¤½Å°ú) |
Neuropsychiatric omain
(À±Àοµ, ¼¿ïÀÇ´ë Á¤½Å°ú) |
New trends in palatal surgery
(±è¼º¿Ï, °æÈñÀÇ´ë À̺ñÀÎÈÄ°ú) |
Adolescents
(±èÁöÇö, ´Ü±¹ÀÇ´ë ½Å°æ°ú) |
Cardiovascular disese
(³²Çö¿ì, ¼¿ïÀÇ´ë ½Å°æ°ú) |
Maxillo-mandibular advancement surgery for OSA
(Ȳ¼øÁ¤, ¼¿ïÄ¡´ë ±¸°¾Ç¾È¸é¿Ü°ú) |
Elderly
(¹è°æ¿, Àü³²´ëº´¿ø Á¤½Å°ú) |
To treat or not to treat PLMS in relation with sequale of PLMS
(Á¤±â¿µ, °í·ÁÀÇ´ë ½Å°æ°ú) |
14:10~15:30 |
Oral Presentation |
English (ÁÂÀå : ÀÌÁ¤Èñ, ½Å½ÂÇå) |
Korean I (ÁÂÀå : ±èÁÖÇÑ, ±èÁ¤¼ö) |
Korean II (ÁÂÀå : À±Ã¢È£, ±è¼ºÅÃ) |
15:30~15:50 |
Coffee Break |
15:50~17:00 Sym-¥²
(*15:45 - 17:05) |
Recent advances in treatment of OSA -II* (ÁÂÀå : ÃÖÀç°©) |
Pediatric OSA (ÁÂÀå : ä±Ô¿µ) |
Impact of short sleep and nocturia (ÁÂÀå : È«½Âö) |
Updates on oral appliance for treating OSA: patient selection and predictors of treatment success
(Á¤Áø¿ì, ¼¿ïÄ¡´ë ±¸°³»°ú) |
Consequences of pediatric OSA
(¼ÇýÀº, °æºÏÀÇ´ë ¼Ò¾Æ°ú) |
Nocturia and EDS
(±è¿ëÅÂ, ÇѾçÀÇ´ë ºñ´¢±â°ú) |
Complication of oral appliance for OSA patients
(¾ÈÇüÁØ, ¿¬¼¼Ä¡´ë ±¸°³»°ú) |
Recent update of biomarker in pediatric OSA
(À̽ÂÈÆ, °í·ÁÀÇ´ë À̺ñÀÎÈÄ°ú) |
Short sleep and obesity / cardiometabolic disease (½Åö, °í·Á´ëÇб³ ¾È»êº´¿ø È£Èí±â³»°ú) |
Treatment other than PAP and surgery (¿°È£±â, ÀÎÁ¦´ëÇб³¼¿ï¹éº´¿ø È£Èí±â³»°ú) |
Risk factor of pediatric OSA: beyond adenotonsillar hypertrophy
(Á¤À¯»ï, ¿ï»êÀÇ´ë À̺ñÀÎÈÄ°ú) |
Short sleep and mortality
(ÀÌÇâ¿î, ÀÌÈ¿©´ë ½Å°æ°ú) |
Neuromodulation of upper airway in OSA (hypoglossal nerve stimulation)
(±èÁ¤ÈÆ, ¼¿ï´ë À̺ñÀÎÈÄ°ú) |
¡¡ |
¡¡ |